Standard Biotools (LAB) Other Non Operating Income (2010 - 2026)
Standard Biotools (LAB) posted quarterly Other Non Operating Income of -$5.6 million for Q1 2026, down 1092.95% year-over-year from $567000.0 in Q1 2025, and down 688.91% quarter-over-quarter from $956000.0 in Q4 2025.
Standard Biotools (LAB) Other Non Operating Income (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Other Non Operating Income for 17 consecutive years, with -$5.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 1092.95% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at -$4.7 million (up 84.02% YoY), while the FY2025 annual figure was $4.4 million, up 187.74% from the prior year.
- Other Non Operating Income fell to -$5.6 million in Q1 2026 per LAB's latest filing, from $956000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.1 million in Q1 2023 and bottomed at -$30.2 million in Q4 2024.
- Historically, Other Non Operating Income has averaged -$3.3 million across 5 years, with a median of -$63000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Non Operating Income jumped 857.63% — and 2026, when it plunged 1092.95%.
- Standard Biotools' Other Non Operating Income stood at -$699000.0 in 2022, then soared by 261.66% to $1.1 million in 2023, then tumbled by 2774.42% to -$30.2 million in 2024, then jumped by 103.16% to $956000.0 in 2025, then slumped by 688.91% to -$5.6 million in 2026.
- Business Quant data shows LAB's Other Non Operating Income at -$5.6 million in Q1 2026, $956000.0 in Q4 2025, and $567000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Standard Biotools | 260.01 Mn | -216.70 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -658,000.00 |
| Mar 31, 2026 | -5.63 Mn |
| Dec 31, 2025 | 956,000.00 |
| Mar 31, 2025 | 567,000.00 |
| Dec 31, 2024 | -30.22 Mn |
| Jun 30, 2024 | 412,000.00 |
| Mar 31, 2024 | -2.23 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | -699,000.00 |
| Sep 30, 2022 | -63,000.00 |
| Jun 30, 2022 | -174,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Sep 30, 2021 | 534,000.00 |
| Jun 30, 2021 | 504,000.00 |
| Mar 31, 2021 | -285,000.00 |
| Dec 31, 2020 | 248,000.00 |
| Sep 30, 2020 | 107,000.00 |
| Jun 30, 2020 | 463,000.00 |
| Mar 31, 2020 | -818,000.00 |
| Dec 31, 2019 | -3.00 Mn |